USMF logo

Institutional Repository in Medical Sciences
of Nicolae Testemitanu State University of Medicine and Pharmacy
of the Republic of Moldova
(IRMS – Nicolae Testemitanu SUMPh)

Biblioteca Stiintifica Medicala
DSpace

University homepage  |  Library homepage

 
Please use this identifier to cite or link to this item: http://hdl.handle.net/20.500.12710/34412
Title: IMPORTANCE OF FLOW CYTOMETRY IN ACUTE LEUKEMIA
Authors: Malavika, Sathyajith
Keywords: acute leukemia;flow cytometry;minimal residual disease;targeted therapy
Issue Date: 2026
Publisher: Centrul Editorial-Poligrafic Medicina
Citation: Malavika, Sathyajith. IMPORTANCE OF FLOW CYTOMETRY IN ACUTE LEUKEMIA. In: MedEspera 2026, p. 597. ISBN 978-9975-82-486-6.
Abstract: Introduction. Acute leukemia (AL) is a hematological neoplasm, with increase of myeloblasts or lymphoblasts in the bone marrow or peripheral blood. Appropriate assessment, classification and treatment are important because of its diverse phenotype and lineage. Flow cytometry (FCM) is a highly applicable immunophenotyping method in clinical practice. It plays a significant role in differentiation of the type of Acute leukemia (AL) and minimal residual disease (MRD). Aim of study. Studying the impact of flow cytometry based on contemporary literature. Methods and materials. A systematic literature review was conducted using databases such as: PubMed, ResearchGate, ScienceDirect and Google Scholar. The search was conducted filtering articles that were focused on Acute leukemia. Results. Precise classification of AL is important for its patient specific management and treatment as it has different morphology, phenotype and lineage in each patient . FCM is the most standard technology which uses specific scatter properties in identifying the subtypes of acute myeloid leukemia (AML) and acute lymphoid leukemia (ALL) as morphology and cytochemistry alone has its own limitations. It can identify aberrant phenotypes, its surface antigens, immune markers, intracellular cytokines by using two main plots, Forward scatter (FSC) were the size of the cell and Side scatter (SSC) in which internal complexity and granularity of the cell is analysed. Multiparameter flow cytometry studies the pattern of events and each specimen is run through different tubes each of B-cell markers, T-cell markers, Myeloid markers etc and is compared with the templates created. CD-45 gating, also called cornerstone in acute leukemia, is a fundamental step in differentiating AML and ALL and is the most important prognostic tool in identifying relapse. FCM identifies leukemia associated immunophenotypes (LAIP’s) in rare blast cells retained even after treatment, called minimal residual disease (MRD), that helps in early detection of relapse. Studies have also shown that FCM is helpful in identifying rare pattern acute leukemias, that is approximately 1 to 5% of total AL, which can either be acute undifferentiated leukemias or mixed phenotypic leukemias(MPAL). Conclusions. In conclusion, FCM detects surface antigens and thereby is used in providing personalised and targeted therapy by monoclonal antibodies. Rather than treatment, it is a principal diagnostic approach in detection of MRD in AML patients even after achieving complete remission after treatment.
metadata.dc.relation.ispartof: MedEspera 2026. The 11th International Medical Congress for Students and Young Doctors, 6-8 May 2026
URI: https://medespera.md/documents/abstract-book-4.pdf
https://repository.usmf.md/handle/20.500.12710/34412
ISBN: 978-9975-82-486-6
Appears in Collections:MedEspera 2026

Files in This Item:
File Description SizeFormat 
M-597.pdf467.3 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

 

Valid XHTML 1.0! DSpace Software Copyright © 2002-2013  Duraspace - Feedback